308 related articles for article (PubMed ID: 18226885)
21. Nanocrystals as tool to improve piroxicam dissolution rate in novel orally disintegrating tablets.
Lai F; Pini E; Angioni G; Manca ML; Perricci J; Sinico C; Fadda AM
Eur J Pharm Biopharm; 2011 Nov; 79(3):552-8. PubMed ID: 21820052
[TBL] [Abstract][Full Text] [Related]
22. Characterization of physico-chemical properties and pharmaceutical performance of sucrose co-freeze-dried solid nanoparticulate powders of the anti-HIV agent loviride prepared by media milling.
Van Eerdenbrugh B; Froyen L; Martens JA; Blaton N; Augustijns P; Brewster M; Van den Mooter G
Int J Pharm; 2007 Jun; 338(1-2):198-206. PubMed ID: 17363200
[TBL] [Abstract][Full Text] [Related]
23. Effect of powder characteristics on oral tablet disintegration.
Yamamoto Y; Fujii M; Watanabe K; Tsukamoto M; Shibata Y; Kondoh M; Watanabe Y
Int J Pharm; 2009 Jan; 365(1-2):116-20. PubMed ID: 18804156
[TBL] [Abstract][Full Text] [Related]
24. An investigation into the effects of excipient particle size, blending techniques and processing parameters on the homogeneity and content uniformity of a blend containing low-dose model drug.
Alyami H; Dahmash E; Bowen J; Mohammed AR
PLoS One; 2017; 12(6):e0178772. PubMed ID: 28609454
[TBL] [Abstract][Full Text] [Related]
25. Enhancement of famotidine dissolution rate through liquisolid tablets formulation: in vitro and in vivo evaluation.
Fahmy RH; Kassem MA
Eur J Pharm Biopharm; 2008 Aug; 69(3):993-1003. PubMed ID: 18396390
[TBL] [Abstract][Full Text] [Related]
26. Influence of dry granulation on compactibility and capping tendency of macrolide antibiotic formulation.
Bozic DZ; Dreu R; Vrecer F
Int J Pharm; 2008 Jun; 357(1-2):44-54. PubMed ID: 18308490
[TBL] [Abstract][Full Text] [Related]
27. Evidence of a metastable form of fenofibrate.
Di Martino P; Palmieri GF; Martelli S
Pharmazie; 2000 Aug; 55(8):625-6. PubMed ID: 10989846
[No Abstract] [Full Text] [Related]
28. Tableting and tablet properties of alginates: characterisation and potential for Soft Tableting.
Schmid W; Picker-Freyer KM
Eur J Pharm Biopharm; 2009 May; 72(1):165-72. PubMed ID: 18992337
[TBL] [Abstract][Full Text] [Related]
29. Formulation and evaluation of dried yeast tablets using different techniques.
Al-Mohizea AM; Ahmed MO; Al-jenoobi FI; Mahrous GM; Abdel-Rahman AA
Eur J Pharm Biopharm; 2007 Aug; 67(1):253-9. PubMed ID: 17270410
[TBL] [Abstract][Full Text] [Related]
30. Process design applied to optimise a directly compressible powder produced via a continuous manufacturing process.
Gonnissen Y; Gonçalves SI; De Geest BG; Remon JP; Vervaet C
Eur J Pharm Biopharm; 2008 Mar; 68(3):760-70. PubMed ID: 17964129
[TBL] [Abstract][Full Text] [Related]
31. A novel fast disintegrating tablet fabricated by three-dimensional printing.
Yu DG; Branford-White C; Yang YC; Zhu LM; Welbeck EW; Yang XL
Drug Dev Ind Pharm; 2009 Dec; 35(12):1530-6. PubMed ID: 19929213
[TBL] [Abstract][Full Text] [Related]
32. Raman spectroscopy as a process analytical technology (PAT) tool for the in-line monitoring and understanding of a powder blending process.
De Beer TR; Bodson C; Dejaegher B; Walczak B; Vercruysse P; Burggraeve A; Lemos A; Delattre L; Heyden YV; Remon JP; Vervaet C; Baeyens WR
J Pharm Biomed Anal; 2008 Nov; 48(3):772-9. PubMed ID: 18799281
[TBL] [Abstract][Full Text] [Related]
33. A Holistic Multi Evidence Approach to Study the Fragmentation Behaviour of Crystalline Mannitol.
Koner JS; Rajabi-Siahboomi A; Bowen J; Perrie Y; Kirby D; Mohammed AR
Sci Rep; 2015 Nov; 5():16352. PubMed ID: 26553127
[TBL] [Abstract][Full Text] [Related]
34. Advantages of celecoxib nanosuspension formulation and transformation into tablets.
Dolenc A; Kristl J; Baumgartner S; Planinsek O
Int J Pharm; 2009 Jul; 376(1-2):204-12. PubMed ID: 19426794
[TBL] [Abstract][Full Text] [Related]
35. Differential scanning calorimetry to investigate the compatibility of ciprofloxacin hydrochloride with excipients.
Fathy M; Hassan MA; Mohamed FA
Pharmazie; 2002 Dec; 57(12):825-8. PubMed ID: 12561245
[TBL] [Abstract][Full Text] [Related]
36. Investigation of preparation parameters of nanosuspension by top-down media milling to improve the dissolution of poorly water-soluble glyburide.
Singh SK; Srinivasan KK; Gowthamarajan K; Singare DS; Prakash D; Gaikwad NB
Eur J Pharm Biopharm; 2011 Aug; 78(3):441-6. PubMed ID: 21439378
[TBL] [Abstract][Full Text] [Related]
37. Improving the wetting and dissolution of ibuprofen using solventless co-milling.
Varghese S; Ghoroi C
Int J Pharm; 2017 Nov; 533(1):145-155. PubMed ID: 28951348
[TBL] [Abstract][Full Text] [Related]
38. Differential scanning calorimetry as a screening technique in compatibility studies of DHEA extended release formulations.
Mora PC; Cirri M; Mura P
J Pharm Biomed Anal; 2006 Sep; 42(1):3-10. PubMed ID: 16574368
[TBL] [Abstract][Full Text] [Related]
39. Adsorption of pharmaceutical excipients onto microcrystals of siramesine hydrochloride: effects on physicochemical properties.
Zimmermann A; Millqvist-Fureby A; Elema MR; Hansen T; Müllertz A; Hovgaard L
Eur J Pharm Biopharm; 2009 Jan; 71(1):109-16. PubMed ID: 18619536
[TBL] [Abstract][Full Text] [Related]
40. Physicochemical and pharmacokinetic characterization of water-soluble Coenzyme Q(10) formulations.
Hatanaka J; Kimura Y; Lai-Fu Z; Onoue S; Yamada S
Int J Pharm; 2008 Nov; 363(1-2):112-7. PubMed ID: 18706989
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
